Why these two founders chose Nasdaq over a red-hot Indian stock market

Company Overview - SSI International transitioned from financial struggles in 2023 to a successful Nasdaq listing in 2025, achieving a market cap exceeding $1 billion [1] - The company, founded by Sudhir Srivastava, has established itself in the medical technology sector, particularly in robotic surgical systems, competing with industry leader Intuitive Surgical [2] Business Development - SSI International has made significant progress since 2015, now shipping surgical systems weekly, with at least 115 units deployed across major hospitals in India and several other countries [3] - The company reported trailing 12-month revenue of $27.6 million as of June and has engaged an investment bank for public fundraising [4] Market Strategy - SSI went public through a merger with Avra Medical Robotics, allowing it to bypass traditional IPO processes [4] - The company aims to maintain capital efficiency in its operations, as emphasized by co-founder Shiladitya Sengupta [6] Industry Context - Vyome Therapeutics, another Indian biotech firm, successfully listed on Nasdaq via a reverse merger, highlighting a trend among Indian companies seeking alternative routes to public markets [5]